| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |